1. Department of Oncology, Institute of Clinical Science, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden;
2. Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland;
3. Oslo University Hospital, Oslo, Norway;
4. Department of Oncology and Radiotherapy, Oulu University Hospital, MRC Oulu, Oulu, Finland;
5. Novartis Healthcare A/S, Copenhagen, Denmark;
6. Commercialization & Outcomes, ICON plc, Stockholm, Sweden;
7. Commercialization & Outcomes, ICON plc, Lyon, France;
8. Institute of Clinical Medicine, Campus AHUS, University of Oslo, Oslo, Norway;
9. Department of Oncology, Akershus University Hospital, Lørenskog, Norway